-
Optimizing Profitability in Drug Product Manufacturing with Hard-Shell Capsules
Hard-shell capsules are more simple to formulate and easier to produce than other types of solid dose.
PAP-Q3-18-CL-003 -
Patient Centricity and the Pharmaceutical Supply Chain: An Evolving Dynamic
Becoming a true patient-centric industry requires significant effort and a complete change in the way pharmaceutical companies operate.
PAP-Q3-18-NI-004 -
Dedicated CDMO Services Meet Customer Needs in the Dynamic Biopharma Sector
Biologic drug substances are increasingly complex, and as such their sophisticated biomanufacturing is exceedingly challenging.
PAP-Q3-18-CL-004 -
Aspects to Consider on the Way to a Tailored Manufacturing Strategy
Often, the best decision for a company’s bottom line is to rely on an experienced manufacturing partner.
PAP-Q3-18-CL-005 -
People, Expertise and Dedication are Key to Successful Strategic Partnerships
Strategic partnerships are all about dedicating people to work togethe, so that all available expertise is accessible for a project’s success.
PAP-Q3-18-CL-006 -
Leveraging Offsite Fabrication in the Pharma Industry
Leveraging offsite fabrication offers a range of benefits, including improved safety, schedule predictability and reduced costs.
PAP-Q3-18-CL-007 -
Analytical Methodologies Utilized in Therapeutic Viral Vector Manufacturing
Given the range of impurities that can be present in viral vector drug substance/drug product, diverse analytical techniques are needed.
PAP-Q3-18-CL-001 -
Understanding the Unique Design and Engineering Needs for Gene Therapy Production
Designing gene therapy manufacturing facilities requires applying existing technologies and systems in new ways.
PAP-Q3-18-CL-008 -
A Biopharmaceutical Leader Emerges
For Polpharma Biologics, the new website reflects the vision to become a trusted source of biopharmaceutical products and services.
PAP-Q3-18-NI-002 -
A Vision for Growth Tailored to Our Partners’ Needs
We constantly seek opportunities for improvement –– in how we deliver our products, process orders, develop new products and communicate with our partners.
PAP-Q3-18-CL-009 -
Accelerating Time to Market with Integrated Preparative Chromatography Support
While preparative chromatography can enable difficult separations, it requires specialized equipment and expertise.
PAP-Q3-18-CL-010 -
Creating Value with Tailored ODT Solutions
One approach is to use a commercially available orally dispersible drug delivery platform to facilitate development and speed to market.
PAP-Q3-18-CL-011 -
Pursuing Patient Centricity from Start to Finish
Patient centricity must be integrated into every area and aspect of the supply chain.
PAP-Q3-18-NI-005 -
Remember the User – Incorporating Patient Centricity into Drug Design
Developers must consider what works for patients and how this design will be adopted in a real-world context.
PAP-Q3-18-NI-006 -
The Impact of Patients as Consumers: New Fill/Finish and Packaging Solutions
Poor medication adherence continues to be a huge issue for the pharmaceutical industry.
PAP-Q3-18-NI-007 -
Personalized Logistics Solutions for Virtual and Hybrid Clinical Trials
The key to a successful hybrid trial is understanding which aspects will include patient home care and DTP/DFP trial components.
PAP-Q3-18-CL-002 -
New Look, Same Unwavering Patient Commitment
Marken is both a service and technology provider, so user experience and functionality were key considerations in redesigning its website.
PAP-Q3-18-NI-001 -
Competitive Generic Therapy: A New Patient-Centric FDA Pathway
The CGT pathway was designed to incentivize the development of generics for drugs for which there is effectively no market competition.
PAP-Q3-18-NI-008 -
Increasing Customer Successes Through Enhanced QC Agility and Flexibility
The development of increasingly complex drug substances requires associated advances in testing.
PAP-Q3-18-CL-012 -
Continuing on the Acquisition Trail: Building Out a World-Class, Customer-Oriented CDMO
At the core of each acquisition decision is the potential to improve the customer experience.
PAP-Q3-18-CL-013 -
Aligning with Sponsors for Strategic Growth
Alcami’s ultimate goal is to become an industry-leading CDMO focused on small and mid-sized pharma customers.
PAP-Q3-18-CL-014 -
Terminal Sterilization for Parenteral Drugs: Finding the Right CDMO Partner
Selecting an appropriate sterilization method requires an understanding of the drug substance and the final formulated product.
PAP-Q3-18-CL-015 -
Meeting Regulatory Requirements: Rising to the Challenge with a Trusted Equipment Partner
In order for a company to fully prepare for and conform to all DSCA measures, updated equipment is a must.
PAP-Q3-18-CL-016 -
The Biotech Boom
Regardless of whether a biotech company has demonstrated results, it is perceived to have intrinsic value.
PAP-Q3-18-NI-003
-
Personalized Logistics Solutions for Virtual and Hybrid Clinical Trials
Ariette van Strien, Chief Commercial Officer, Marken, discusses siteless/hybrid clinical trials.
-
Designing Effective Drug Formulations: Keys to Successful Proof of Concept Services
Ed Scholtz, Ph.D., Vice President of R&D for UPM Pharmaceuticals explains the company's approach to formulations.
-
Meeting the Changing Demands for Sterile-Fill Finish Operations
Justin Kadis, Business Development for Federal Equipment Company, discusses optimized and error-free fill-finish operations.
-
Ensuring Confidence in Viral Vector Manufacturing
Christopher Murphy, Chief Manufacturing Officer and Michael Wourms, Associate Director of Fill Finish for Brammer Bio discuss the company’s viral vector development and manufacturing services.
-
Building a Robust Supply Chain with Dependable Quality Primary Suppliers
Drug manufacturers and their suppliers face a number of challenges, such as downward pricing pressures and the need for flexibility and speed to market, says Dale Martin, General Manager & CFO for CapsCanada.
-
Meeting the Need for Small-Volume API Manufacturing
Jim Scandura, Executive VP, Chief Operating Officer; Gary Butler, Vice President & Avlon Site Director; and Werner Kunz, Vice President & Shannon Site Director at Avara Pharmaceutical Services explain the integrated API service offering.
-
FDA Gives De Novo Clearance to First Over-the-Counter Hearing Aid
The Bose Hearing Aid gives similar results with self-fitting to hearing aids fitted by a health provider.
-
Microsoft Genomics Ventures into the Microbiome With Eagle Genomics
This is the first Microsoft partner focused in the microbiome genomics market.
-
New Study Examines How Pharmaceutical Industry is Embracing Digital Patient Engagement Programs
Patient engagement programs built around digital tools have quickly taken hold in leading pharmaceutical, biotechnology and medical device organizations across global, emerging and developed markets.
-
PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal Surgical Site Infections
Study to enroll up to 300 patients; with top-line results expected in the second half of 2019.
-
Continuing on the Acquisition Trail: Building Out a World-Class, Customer-Oriented CDMO
Tim Tyson, Chairman and CEO of Avara Pharmaceutical Services, discusses the company's acquisition strategy.
-
Facilitating Implementation and Customer Service with Offline Serialization
Tyler Ewald, Associate Director, Manufacturing and Joseph Quales, Supervisor, Label Control at UPM Pharmaceuticals explain the company’s offline serialization system.
-
Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing
Richard Snyder, Ph.D., Chief Scientific Officer and Founder; Christopher Murphy, Chief Manufacturing Officer; Susan D'costa, VP Development and Cameron Jones, Quality Assurance Director at Brammer Bio explain how to strengthen security of supply in viral vector manufacturing.
-
Transforming with an Equipment Partner: Preparing the Industry for Serialization
Justin Kadis, Business Development for Federal Equipment Company explains the link between the serialization mandate and pharma equipment.
-
Optimizing Profitability in Drug Product Manufacturing with Hard-Shell Capsules
Steve Lee, Technical Service Manager, CapsCanada, explains cost savings with hard-shell capsules.
-
Achieving Successful Treatment Outcomes Through the Delivery of Manufacturing Services
Janice Graff, Director of Finished Product Sales & Business Development and KaShauna G. Rohlehr PMP, Program Manager at GSK Contract Manufacturing explain the company’s commitment and expertise in the development and commercialization of novel biotherapies.
-
New Collaboration Aimed at Improving Cancer Diagnostics in the UK
IQVIA and Genomics England will be offering a new solution for researchers to develop custom clinical–genomic data sets.
-
Mallinckrodt's Stratatech Company Awarded $26 Million in Additional BARDA Funding for Pediatric Studies of StrataGraft® Skin Tissue in Thermal Burns
The latest award will provide support for pediatric studies related to the company's StrataGraft® viable, engineered skin tissue.
-
GHIT Fund Welcomes Ono Pharmaceutical Co., Ltd. as New Funding Partner
With the addition of Ono, GHIT now counts 21 public and private organizations as funding partners.
-
UK Hospital to Get Command Center Driven by AI and Real-Time Analytics
GE Healthcare contracted to build at a UK National Health Service (NHS) teaching hospital.
Nice Insight Awareness/Perception Scorecard
Research. Compare. Contact. Find the Ideal Partner.
Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.
- Search by company type, region, market segment and services.
- Select up to 5 companies to compare.
- View CA & CP performance scores against industry benchmark ratings.
Latest
View All LatestFDA Gives De Novo Clearance to First Over-the-Counter Hearing Aid
Oct 16, 2018 11:59:49 AM PAO-M10-18-NI-015New Collaboration Aimed at Improving Cancer Diagnostics in the UK
Oct 16, 2018 11:57:19 AM PAO-M10-18-NI-014UK Hospital to Get Command Center Driven by AI and Real-Time Analytics
Oct 16, 2018 11:53:40 AM PAO-M10-18-NI-013U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar
Oct 12, 2018 2:33:02 PM PAO-M10-18-NI-010New Clinical Trial Will Evaluate Biomarkers as Predictors of Treatment Response in IBD
Oct 12, 2018 2:22:42 PM PAO-M10-18-NI-009
TOPICS
View All TopicsPRESS RELEASES
View All-
Eclipse MedCorp Acquires Transformative Technology in Regenerative Medicine
Oct 19, 2018 5:00:00 AM -
Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial
Oct 19, 2018 5:00:00 AM -
Cellect Announces Positive Clinical Results
Oct 18, 2018 5:00:00 AM
Nice Insight Industry Benchmark Reports 2017
Download Sample Report
